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Intestinal epithelial cells (IECs) regulate gut immune
homeostasis, and impaired epithelial responses are
implicated in thepathogenesis of inflammatorybowel
diseases (IBD). IEC-specific ablation of nuclear factor
kB (NF-kB) essential modulator (NEMO) caused Pan-
eth cell apoptosis and impaired antimicrobial factor
expression in the ileum, as well as colonocyte
apoptosis and microbiota-driven chronic inflamma-
tion in the colon. Combined RelA, c-Rel, and RelB
deficiency in IECs caused Paneth cell apoptosis but
not colitis, suggesting that NEMO prevents colon
inflammation by NF-kB-independent functions.
Inhibition of receptor-interacting protein kinase 1
(RIPK1) kinase activity or combined deficiency of
Fas-associated via death domain protein (FADD)
and RIPK3 prevented epithelial cell death, Paneth
cell loss, and colitis development inmicewith epithe-
lial NEMO deficiency. Therefore, NEMO prevents
intestinal inflammation by inhibiting RIPK1 kinase ac-
tivity-mediated IEC death, suggesting that RIPK1 in-
hibitors could be effective in the treatment of colitis
in patients with NEMOmutations and possibly in IBD.
INTRODUCTION
The maintenance of gut immune homeostasis depends on
mechanisms regulating the interaction between the intestinal mi-crobiota and host epithelial, stromal, and immune cells (Hooper
et al., 2012; Kaser et al., 2010). The intestinal epithelium forms a
physical and biochemical barrier between luminal bacteria and
mucosal immune cells. It actively influences the intestinal micro-
biota by secreting anti-microbial factors andmodulates mucosal
immune responses via the production of immunoregulatory pro-
teins (Hooper et al., 2012; Kaser et al., 2010). Paneth cells,
specialized secretory intestinal epithelial cells found in small in-
testinal crypts, release peptides with anti-microbial activity that
are believed to regulate the gut microbiota (Kaser et al., 2010;
Ouellette, 2010). Deregulation of intestinal immune homeostasis
results in chronic inflammatory bowel diseases, including
Crohn’s disease (CD) and ulcerative colitis (UC). Genetic, micro-
bial, and environmental factors are thought to contribute to the
pathogenesis of IBD; however, the mechanisms responsible
for the initiation and chronicity of intestinal inflammation remain
poorly understood (Blumberg and Powrie, 2012; Kaser et al.,
2010).
Tumor necrosis factor (TNF) plays a critical role in intestinal
inflammation as illustrated by the clinical efficacy of anti-TNF
therapies in CD and UC (Peyrin-Biroulet, 2010). However, the
TNF-dependent molecular and cellular mechanisms that
contribute to the pathogenesis of IBD remain elusive. TNF sig-
nals primarily via TNF receptor 1 (TNFR1) to activate pro-survival
and proinflammatory NF-kB and mitogen-activated protein ki-
nase signaling or, when pro-survival responses are compro-
mised, to induce cell death by FADD-Caspase-8-dependent
apoptosis or RIPK3-mixed lineage kinase domain-like (MLKL)-
mediated necroptosis (Pasparakis and Vandenabeele, 2015).
RIPK1 is a key regulator of TNFR1 signaling that induces prosur-
vival and proinflammatory responses via kinase-independent
scaffolding functions but also apoptosis or necroptosis via itsImmunity 44, 553–567, March 15, 2016 ª2016 The Authors 553
(legend on next page)
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kinase activity (Pasparakis and Vandenabeele, 2015). Recent
studies revealed the important role of kinase-independent
RIPK1 functions in intestinal epithelial homeostasis (Dannappel
et al., 2014; Dillon et al., 2014; Rickard et al., 2014; Takahashi
et al., 2014), but the potential role of RIPK1 kinase activity in in-
testinal inflammation remains unknown.
The NF-kB pathway regulates immune and inflammatory
responses. The NF-kB protein family consists of RelA, c-Rel,
RelB, p50, and p52, which form hetero- and homodimers that
control the transcription of NF-kB target genes by binding to
consensus DNA sites in cis-regulatory regions (Oeckinghaus
and Ghosh, 2009). RelA, c-Rel, and RelB have transcription
transactivation domains, and hence NF-kB dimers containing
these proteins are capable of activating gene expression (Oeck-
inghaus and Ghosh, 2009). p50 and p52 do not contain transac-
tivation domains, and therefore p50 and p52 homodimers do not
activate but rather suppress gene transcription. NF-kB dimers
are kept inactive in resting cells by binding to inhibitor of NF-
kB (IkB) proteins. The IkB kinase (IKK) complex, consisting of
the NEMO (also named IKKg) regulatory subunit and the IKK1
(also named IKKa) and IKK2 (also named IKKb) kinases, acti-
vates NF-kB by phosphorylating IkB proteins, triggering their
ubiquitin-dependent degradation and allowing the nuclear accu-
mulation of NF-kB dimers and the transcription of target genes
(Karin and Greten, 2005; Oeckinghaus and Ghosh, 2009).
Mice with IEC-specific NEMO deficiency develop sponta-
neous colitis that depends on MyD88 and TNFR1 signaling
(Nenci et al., 2007). Interestingly, human patients with ecto-
dermal dysplasia with immunodeficiency (EDA-ID) caused by
hypomorphic NEMO mutations often suffer from colitis that is
not resolved by hematopoietic stem cell transplantation (Fish
et al., 2009; Kawai et al., 2012; Pai et al., 2008; Permaul
et al., 2009), suggesting that NEMO deficiency in stromal cells
also causes colon inflammation in humans. These results sug-
gested that NEMO-mediated NF-kB activation in the intestinal
epithelium is important for the maintenance of intestinal ho-
meostasis in both mice and humans. However, mice lacking
RelA in IECs do not develop spontaneous intestinal inflamma-
tion although they are highly sensitive to Dextran Sulfate So-
dium (DSS)-induced colitis (Steinbrecher et al., 2008), question-
ing to which extent inhibition of NF-kB activation accounts for
the disruption of intestinal epithelial homeostasis and the spon-
taneous development of colitis in mice with IEC-specific NEMO
deficiency.Figure 1. Colitis in NEMOIEC-KO Mice Is Driven by the Microbiota and E
(A) Representative images of colon sections from NEMOIEC-KO and NemoFL litter
(B) Graph depicting scores for inflammation (infl), tissue damage (dam), and overa
16 mice per genotype).
(C) Graph depicting percentage of crypts with cl. casp. 3 stained cells on colon
(D) Graphs depicting mRNA levels of the indicated genes normalized to Tbp in th
(E) Representative images of colon sections from NEMOIEC-KO TNFR1IEC-KO, and
(F) Graph depicting histopathological scores of colon sections from NEMO IEC-KO
(G) Graph depicting percentage of crypts with cl. casp. 3 stained cells on colon s
mice per genotype).
(H) Graphs depicting mRNA levels of the indicated genes in the colon of NEMOIE
(I) Representative images of colon sections from germ-free or germ-free NEMOI
(J–L) Graphs depicting histopathological scores of colon sections, percentage of c
germ-free, conventionalized, and SPF housed NEMOIEC-KO and NemoFL mice (n
Scale bars represent 100 mm. See also Figure S1.Herewe show that NEMOexerts NF-kB-dependent and -inde-
pendent functions that control intestinal homeostasis and
inflammation by inhibiting RIPK1 kinase activity-dependent
death of intestinal epithelial cells. These results revealed an
important role of RIPK1 kinase activity in intestinal homeostasis,
suggesting that RIPK1 kinase inhibitors could be effective for the
treatment of gut inflammation in patients with NEMO mutations
and might also prove beneficial in the therapy of IBD.
RESULTS
Epithelial TNFR1 Signaling and the Microbiota Drive
Colitis in NEMOIEC-KO Mice
Mice lackingNEMOspecifically in IECs (Ikbkgfl/fl or Ikbkgfl/YVillin-
cretg/WT, hereafter referred to as NEMOIEC-KO) spontaneously
developed chronic colitis, manifesting with diarrhea, thickening
of the colonic wall, epithelial erosion, and ulcer formation,
increased infiltration of immune cells in the mucosa and submu-
cosa, and increasedmRNAexpression of pro-inflammatory cyto-
kines and chemokines such as Tnf, Il1b, Cxcl1, Ccl2, and Ccl5
(Figures 1A–1D). Increased numbers of apoptotic IECs, identified
by staining for cleaved caspase-3, were detected in colonic
crypts from NEMOIEC-KO mice (Figures 1A and 1C). We showed
previously that systemic TNFR1deficiency inhibited colitis devel-
opment in NEMOIEC-KO mice (Nenci et al., 2007). To address
whether IEC-intrinsic TNFR1 signaling triggered colitis in
NEMOIEC-KO mice, we crossed them with mice carrying loxP-
flanked TNFR1 alleles (Tnfrsf1afl/fl) (Van Hauwermeiren et al.,
2013). IEC-specific knockout of TNFR1preventedcolonic epithe-
lial cell death and the development of colitis in NEMOIEC-KO mice
as shown by histological and cytokine expression analysis
(Figures 1E–1H). Therefore, epithelial-intrinsic TNFR1 signaling
induces colonocyte death and colitis in NEMOIEC-KO mice.
The death of NEMO-deficient IECs was proposed to trigger
colitis in NEMOIEC-KO mice by disrupting the intestinal barrier
allowing luminal bacteria to invade the mucosa and induce
TLR-mediated inflammation (Nenci et al., 2007; Pasparakis,
2009). Indeed, NEMOIEC-KO mice raised under germ-free
conditions did not develop colon inflammation and showed
reduced numbers of apoptotic IECs (Figures 1I–1L, S1). Conven-
tionalization of germ-free NEMOIEC-KO mice by co-housing with
SPFmice resulted in the development of colitis within 2–4 weeks
(Figures 1I–1L, S1). Thus, intestinal bacteria trigger colitis in
NEMOIEC-KO mice.pithelial TNFR1 Signaling
mates stained with H&E or immunostained for cleaved caspase-3 (cl. casp3).
ll histopathology of colon sections from NEMOIEC-KO andNemoFL mice (n = 11–
sections of NEMOIEC-KO and NemoFL mice (n = 5 or 6 mice per genotype).
e colon of NEMOIEC-KO and NemoFL mice (n = 7 mice per genotype).
NemoFL Tnfr1FL littermates.
TNFR1IEC-KO, and NemoFL Tnfr1FL mice (n = 4–6 mice per genotype).
ections of NEMOIEC-KO TNFR1IEC-KO, and NemoFL Tnfr1FL littermates (n = 4–6
C-KO TNFR1IEC-KO, and NemoFL Tnfr1FL mice (n = 4–6 mice per genotype).
EC-KO and NemoFL mice 4 weeks after cohousing with SPF animals.
rypts with cl. casp. 3 stained colon IECs, andmRNA levels of Tnf in colons from
= 3–11 mice per genotype).
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Figure 2. Reduced Paneth Cell Numbers and Increased IEC Apoptosis in Ileal Crypts of NEMOIEC-KO Mice
(A and G) Representative images of ileal sections from NEMOIEC-KO and NemoFL, NEMOtamIEC-KO, and NemoFL littermates 8 days after tamoxifen administration
stained with H&E or immunostained for cl. casp3 or lysozyme.
(B andK) Graph depicting histopathological scores of ileal sections fromNEMOIEC-KO andNemoFL, NEMOtamIEC-KO andNemoFL littermates 8 days after tamoxifen
administration (n = 6–9 mice per genotype).
(C, F, J, and L) Graphs depicting mRNA levels of the indicated genes in the ileum of NEMOIEC-KO and NemoFL mice and NEMOtamIEC-KO and NemoFL littermates
8 days after tamoxifen administration (n = 5–8 mice per genotype).
(D and H) Graphs depicting percentage of crypts with cl. casp. 3 stained IECs on ileal sections from NEMOIEC-KO and NemoFL mice and NEMOtamIEC-KO and
NemoFL littermates 8 days after tamoxifen administration (n = 6–8 mice per genotype).
(E and I) Graphs depicting Paneth cell scores of ileal sections from NEMOIEC-KO and NemoFL mice and NEMOtamIEC-KO and NemoFL littermates 8 days after
tamoxifen administration (n = 6–9 mice per genotype).
Scale bars represent 100 mm. See also Figure S2.NEMOIEC-KO Mice Show a Severe Lack of Paneth Cells
The ileum of NEMOIEC-KO mice did not show epithelial erosion
but had mildly increased immune cell infiltration although
mRNA levels of Tnf and Il1b were not elevated (Figures 2A–2D,556 Immunity 44, 553–567, March 15, 2016 ª2016 The AuthorsFigure S2A). Increased numbers of apoptotic IECs were almost
exclusively detected in the crypt area and were rarely found in
the villus. The number of Paneth cells, identified by their charac-
teristic granule-filled morphology as well as by immunostaining
(legend on next page)
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for lysozyme was strongly reduced in NEMOIEC-KO mice (Figures
2A and 2E). In addition, NEMOIEC-KO mice showed strongly
reduced mRNA expression of anti-microbial factors produced
specifically by Paneth cells including Lyz1, Defa-rs1, and Ang4
(Figure 2F).
To assess whether the absence of Paneth cells in NEMOIEC-KO
mice reflected developmental or differentiation defects or
whether it was caused by cell death, we employed mice allowing
tamoxifen-inducibleablationofNEMO in IECs (Ikbkgfl/fl or Ikbkgfl/Y
Villin-creERT2tg/WT, hereafter referred toasNEMOtamIEC-KOmice).
NEMOtamIEC-KO and Nemofl littermate controls that did not carry
the Villin-creERT2 transgene were injected intraperitoneally with
1 mg tamoxifen on 5 consecutive days and were sacrificed on
day 5 or day 8 for analysis. This protocol resulted in efficient
NEMO ablation and activation of caspase-3 in IECs (Figure S2I).
Immunostaining of ileal sections fromNEMOtamIEC-KOmice sacri-
ficed on day 5 did not reveal considerable tissue damage and
inflammation or Paneth cell loss, although small numbers of
apoptotic IECs were detected mainly in the crypt base (Figures
S2B–S2D). However, 8 days after the first tamoxifen injection
NEMOtamIEC-KO mice showed moderate tissue damage and
immune cell infiltration, as well as strongly reduced numbers of
Paneth cells and diminished expression of Paneth cell markers,
accompanied by an increased number of apoptotic IECs in
small intestinal crypts (Figures 2G–2K). Considering that Paneth
cells are long lived with an estimated turnover time of about
60 days (Ireland et al., 2005), the finding that inducible NEMO
deficiency resulted in Paneth cell loss within 8 days suggests
that NEMO-deficient Paneth cells died, most likely by apoptosis
as indicated by the presence of cleaved caspase-3-positive
cells in intestinal crypts. Inflammatory cytokines and chemokines
were not upregulated in the ileum of NEMOtamIEC-KO mice (Fig-
ure 2L), showing that the increased number of apoptotic
IECs and the loss of Paneth cells did not trigger inflammation.
Tamoxifen-inducible NEMO knockout caused increased IEC
apoptosis, pronounced tissue damage, immune cell infiltration
and strongly increased inflammatory cytokine and chemokine
expression in the colon (FiguresS2E–S2H). These results showed
that epithelial NEMO deficiency caused Paneth cell death in ileal
crypts.
Microbiota- and Death Receptor-Independent Paneth
Cell Loss in NEMOIEC-KO Mice
Our results presented above showed that epithelial intrinsic
TNFR1 signaling induces the death of NEMO-deficient colono-
cytes triggering microbiota-driven colitis in NEMOIEC-KO mice.
To assess whether similar mechanisms contribute to PanethFigure 3. Paneth Cell Death in NEMOIEC-KO Mice Is Independent of the
(A and F) Representative images of ileal sections from germ-free NEMOIEC-KO an
(B and I) Graphs depicting Paneth cell scores of ileal sections from germ-free NEM
mice (n = 5–9 mice per genotype).
(C and J) Graphs depicting mRNA levels of the indicated genes in the ileum of ge
NemoFL DRFL mice (n = 3–7 mice per genotype).
(D and H) Graphs depicting the percentage of crypts with cl. casp. 3 stained cell
NEMOIEC-KO DRIEC-KO and NemoFL DRFL mice (n = 5–9 mice per genotype).
(E and G) Graphs depicting histopathological scores of ileal sections from germ
NemoFL DRFL mice (n = 5–9 mice per genotype).
Scale bars represent 100 mm. See also Figure S3.
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germ-free animals. Paneth cell numbers and the expression of
Paneth cell-derived antimicrobial factors was strongly reduced
in germ-free NEMOIEC-KO mice compared to NemoFL littermates
(Figures 3A–3C). Moreover, germ free NEMOIEC-KOmice showed
IEC apoptosis in ileal crypts and tissue damage, albeit to a
reduced extent compared to SPF mice (compare Figures 3D
and 3E and 2A–2F).
We next asked whether TNFR1 signaling also triggered IEC
death and Paneth cell loss in the small intestine of NEMOIEC-KO
mice. Examination of ileal sections from NEMOIEC-KO
TNFR1IEC-KO mice revealed that IEC-specific TNFR1 deficiency
did not diminish IEC apoptosis, tissue damage, and loss of
Paneth cells (Figures S3A–S3E). To address whether Fas or
TRAILR2, presumably acting in a redundant fashion with
TNFR1, could be involved in triggering the death of NEMO-defi-
cient Paneth cells, we generated NEMOIEC-KO mice with simulta-
neous IEC-specific ablation of TNFR1, Fas, and TRAILR2
(Ikbkgfl/fl or Ikbkgfl/Y Tnfrsf1afl/fl Fasfl/fl Tnfrsf10bfl/fl Villin-cretg/WT,
hereafter referred to as NEMOIEC-KO DRIEC-KO) (Figures S3F–
S3H). Even the combined loss of TNFR1, Fas and TRAILR2
could not prevent Paneth cell loss and tissue damage in ilea of
NEMOIEC-KO DRIEC-KO animals, although it mildly reduced the
number of apoptotic IECs (Figures 3F–3J, compare with Figures
2A–2F). Thus, Paneth cell loss in NEMOIEC-KO mice occurred
independently of the microbiota and death receptor signaling.
Combined Deficiency of FADD and RIPK3 Prevents
Paneth Cell Loss and Colitis in NEMOIEC-KO Mice
Most dying IECs in the intestine of NEMOIEC-KO mice stained
positive for cleaved caspase-3 suggesting that they die primarily
by apoptosis. We therefore sought to address whether IEC
apoptosis triggers the intestinal pathology of NEMOIEC-KO mice
by crossing them with mice carrying loxP-flanked alleles of
FADD (Faddfl/fl), an adaptor protein that is essential for cas-
pase-8-dependent apoptosis. NEMOIEC-KO FADDIEC-KO mice
developed colitis and failed to thrive (data not shown), showing
that FADD ablation did not prevent colon inflammation. As
mice lacking FADD in IECs develop spontaneous colitis due to
RIPK3-dependent epithelial cell necroptosis (Welz et al., 2011),
we reasoned that necroptosis of IECs lacking both NEMO and
FADD could trigger colitis in NEMOIEC-KO FADDIEC-KO mice.
Indeed, NEMOIEC-KO FADDIEC-KO Ripk3/mice developed nor-
mally and did not showmacroscopic signs of colitis. Histological
analysis revealed a normal colonic mucosa without signs of
epithelial erosion, tissue damage, and inflammatory cell infiltra-
tion (Figures 4A–4C), while proinflammatory genes were notMicrobiota and Epithelial Death Receptor Signaling
d NemoFL mice, and of SPF NEMOIEC-KO DRIEC-KO and NemoFL DRFL mice.
OIEC-KO andNemoFLmice, and of SPFNEMOIEC-KO DRIEC-KO andNemoFL DRFL
rm-free NEMOIEC-KO and NemoFL mice, and of SPF NEMOIEC-KO DRIEC-KO and
s on ileal sections from germ-free NEMOIEC-KO and NemoFL mice, and of SPF
-free NEMOIEC-KO and NemoFL mice, and of SPF NEMOIEC-KO DRIEC-KO and
Figure 4. Combined Deficiency in FADD and RIPK3 Prevents IEC Death, Paneth Cell Loss, and Colitis in NEMOIEC-KO Mice
(A and F) Representative images of colon and ileal sections from mice with the indicated genotypes.
(B) Immunoblot analysis of protein extracts from primary small intestinal IECs from mice with the indicated genotypes and with the indicated antibodies.
(legend continued on next page)
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upregulated in the colons of NEMOIEC-KO FADDIEC-KO Ripk3/
mice (Figure 4E). Moreover, NEMOIEC-KO FADDIEC-KO Ripk3/
mice did not show Paneth cell loss in the ileum (Figures 4F–
4K). A few scattered cells staining for cleaved caspase-3 were
observed in the colon and ileum of NEMOIEC-KO FADDIEC-KO
Ripk3/ mice (Figures 4A, 4D, and 4F), but it is not clear
whether these correspond to cells that escaped FADD deletion
or cells undergoing FADD-independent apoptosis. These results
showed that inhibition of apoptosis and necroptosis by com-
bined ablation of FADD and RIPK3 fully protected NEMOIEC-KO
mice from Paneth cell loss and the development of colitis.
Because RIPK3 deficiency in the context of epithelial FADD
knockout fully prevented intestinal pathology in NEMOIEC-KO
mice, we wondered whether RIPK3 might have a role indepen-
dently of FADD. We therefore generated NEMOIEC-KO Ripk3/
mice and found that RIPK3 deficiency ameliorated the severity
of colitis, with about 70% of the examined NEMOIEC-KO Ripk3/
animals (13 out of 17 mice analyzed at the age of 2–6 months)
showing either overall mild inflammation affecting the entire co-
lon or with only focal appearance of inflammatory lesions (Fig-
ures 5A and 5B). The remaining 30% of NEMOIEC-KO Ripk3/
mice developed severe pan-colitis that was histologically indis-
tinguishable from the colitis observed in NEMOIEC-KO mice (Fig-
ures 5A and 5B). Analysis of cytokine and chemokine expression
confirmed that RIPK3 deficiency considerably inhibited inflam-
mation in most NEMOIEC-KO Ripk3/ animals (Figure 5D, S4A).
This variability was observed also within co-housed littermates
suggesting that maternal or housing effects on the microbiota
could not explain the incomplete penetrance of the protective ef-
fect provided by RIPK3 deficiency. Themechanisms responsible
for the variability of colitis severity in NEMOIEC-KO Ripk3/mice
remain elusive at present and might be related to stochastic
events precipitating disease in individual animals. Examination
of ileal tissue from NEMOIEC-KO Ripk3/mice revealed reduced
Paneth cell numbers, decreased expression of Paneth cell
markers and elevated numbers of apoptotic IECs, similarly to
NEMOIEC-KO mice (Figures 5E–5H and S4). Therefore, colitis
development partly depends on RIPK3 while loss of Paneth cells
occurs independently of RIPK3. It remains unclear whether
RIPK3 modulates colitis by contributing to IEC death or by regu-
lating inflammation in a cell-death independent manner.
RIPK1 Kinase Activity-Dependent Death of IECs Causes
Colitis and Paneth Cell Loss in NEMOIEC-KO Mice
To assess whether RIPK1 kinase activity contributes to
IEC death and intestinal pathology in NEMOIEC-KO mice, we
crossed them with knockin mice expressing kinase inactive
mutant RIPK1D138N (Polykratis et al., 2014). NEMOIEC-KO
Ripk1D138N/D138N mice showed a normal colonic mucosa without
signs of inflammation, with only a few scattered apoptotic colo-
nocytes detected (Figures 6A–6D). Moreover, lack of RIPK1 ki-
nase activity also very strongly inhibited IEC apoptosis and loss(C and G) Graphs depicting histopathological scores of colon and ileal sections
(D and I) Graphs depicting the percentage of crypts with cl. casp. 3 stained cells on
6 mice per genotype).
(E, J, and K) Graphs depicting mRNA levels of the indicated genes in the colon an
(H) Graph depicting Paneth cell scores of ileal sections from mice with the indica
Scale bars represent 100 mm.
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mice (Figures 6E–6I).
To obtain insights on the mechanisms triggering the death of
NEMO-deficient IECs, we assessed the formation of the FADD/
Caspase-8 apoptosis-inducing signaling complex. Immunopre-
cipitation of FADD showed that Caspase-8 and RIPK1 strongly
interacted with FADD in colon extracts from NEMOIEC-KO but
not NemoFL or NEMOIEC-KO Ripk1D138N/D138N mice (Figure 6J).
These findings indicate that NEMO deficiency triggers the
RIPK1 kinase activity-dependent formation of a RIPK1/FADD/
Caspase-8 signaling complex that induces apoptosis in IECs.
Collectively, these findings show that RIPK1 kinase activity-
mediated death of IECs causes Paneth cell loss and colitis devel-
opment in NEMOIEC-KO mice.
Epithelial NF-kB Deficiency Causes RIPK1 Kinase-
Dependent PanethCell Loss butDoesNot Trigger Colitis
To addresswhether epithelial NEMOdeficiency causes intestinal
pathology by inhibiting NF-kB activation, we sought to directly
inhibit NF-kB by generating mice with IEC-specific knockout of
NF-kB subunits. As reported earlier (Steinbrecher et al., 2008),
mice with IEC-specific RelA deficiency (Relafl/fl Villin-cretg/WT,
hereafter referred to as RelAIEC-KO) did not develop spontaneous
colitis (Figures S5A–S5D). However, RelAIEC-KO mice showed
increased IEC apoptosis and reduced Paneth cell numbers in
ileal crypts, as well as reduced expression of Paneth-cell-spe-
cific genes (Figures 7A–7E). RelAIEC-KO Ripk1D138N/D138N mice
did not exhibit IEC death and loss of Paneth cells (Figures 7A–
7E), showing that RIPK1 kinase activity induces Paneth cell
death also in RelAIEC-KO mice.
The absence of spontaneous colitis in RelAIEC-KO mice could
be due to compensation of RelA function by other NF-kB sub-
units. To address potential redundancies among NF-kB factors,
we generated mice lacking all three Rel proteins capable to acti-
vate gene transcription (namely RelA, RelB, and c-Rel) specif-
ically in IECs (Relafl/fl Relbfl/fl c-Relfl/fl Villin-cretg/WT, hereafter
referred to as NF-kBIEC-KO mice) (Figure S5F). Combined lack
of RelA, c-Rel, and RelB as well as NEMO deficiency blunted
TNF-induced expression of NF-kB-dependent genes demon-
strating efficient inhibition of NF-kB responses (Figure S5H). In
contrast to NEMOIEC-KO, NF-kBIEC-KO animals did not develop
spontaneous colitis although small numbers of cleaved cas-
pase-3 positive epithelial cells and mild inflammation were de-
tected in the colon of some of these mice (Figures 7F–7I).
Thus, even complete inhibition of NF-kB activity in the intestinal
epithelium was not sufficient to trigger spontaneous colitis
development, suggesting that NEMO prevents colitis via NF-
kB-independent functions. Similarly to RelAIEC-KO, NF-kBIEC-KO
mice showed elevated numbers of apoptotic IECs and Paneth
cell loss in ileal crypts (Figures 7J–7N). However, Paneth cell
loss in NF-kBIEC-KO or RelAIEC-KO mice was not as severe as
in NEMOIEC-KO mice suggesting that inhibition of NF-kBfrom mice with the indicated genotypes (n = 5 or 6 mice per genotype).
colon and ileal sections from littermates with the indicated genotypes (n = 5 or
d ileum of mice with the indicated genotypes (n = 9 or 10 mice per genotype).
ted genotypes (n = 5 or 6 mice per genotype).
Figure 5. RIPK3 Deficiency Ameliorates Colitis but Does Not Prevent Paneth Cell Loss in NEMOIEC-KO Mice
(A and E) Representative images of colon and ileal sections from mice with the indicated genotypes.
(B and F) Graphs depicting histopathological scores of colon and ileal sections from mice with the indicated genotypes (n = 12–17 mice per genotype).
(legend continued on next page)
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activation can only partly explain the loss of Paneth cells in
NEMOIEC-KO mice. These results suggest that NF-kB activity in-
hibits Paneth cell apoptosis in the ileum, but NF-kB-indepen-
dent NEMO functions prevent IEC death and chronic inflamma-
tion in the colon.
RIPK1 Kinase Activity Mediates Embryonic Lethality in
RelA and NEMO Knockout Mice
To address whether the TNF-dependent embryonic lethality of
Rela/mice also depends on RIPK1 kinase activity, we crossed
them to Ripk1D138N/D138N animals. Rela/ Ripk1D138N/D138N
micewere born, albeit at somewhat reduced numbers compared
to the expected Mendelian ratio, but died during the first weeks
of life (Figure S6) most likely due to infections as previously
shown forRela/ Tnfr1/mice (Alcamo et al., 2001). Moreover,
we found that NEMO-deficient mice were also born, though at
reduced ratio, in the Ripk1D138N/D138N genetic background (Fig-
ure S6). Therefore, the embryonic lethality evoked by NEMO or
RelA deficiency is caused, at least in part, by RIPK1 kinase activ-
ity-dependent TNF-induced death of cells in the fetal liver, sug-
gesting that NF-kB activity is essential during embryogenesis
to restrain RIPK1-dependent cell death.
DISCUSSION
Deregulation of intestinal epithelial responses to the microbiota
and the cytokine microenvironment of the gut are believed to
contribute to the pathogenesis of inflammatory bowel diseases
(Blumberg and Powrie, 2012; Hooper et al., 2012; Kaser et al.,
2010). The NF-kB pathway controls cellular responses to
microbes and cytokines and a number of studies suggested
that NF-kB activation in IECs controls intestinal immune homeo-
stasis (Eckmann et al., 2008; Nenci et al., 2007; Steinbrecher
et al., 2008; Zaph et al., 2007). Particularly the finding that
NEMOIEC-KO mice develop spontaneous colitis suggested that
epithelial NF-kB signaling is essential to prevent colon inflamma-
tion (Nenci et al., 2007). NF-kB subunit redundancy and the em-
bryonic lethality ofRelA-deficientmicemade it difficult to address
the functional role of NF-kB signaling in the gut. To overcome
these limitations, we employed conditional targeting of all NF-
kB subunits capable of transcriptional activation, namely RelA,
c-Rel, and RelB, to generate mice lacking NF-kB activity in the
intestinal epithelium. Our studies revealed that even complete
inhibition of NF-kB in IECs did not cause spontaneous colitis as
seen in the NEMOIEC-KO mice, demonstrating that NF-kB activity
in IECs is not essential to prevent colon inflammation under
steady-state conditions. In contrast, NF-kB inhibition caused
IEC death and Paneth cell loss in the small intestine similarly to
NEMO knockout. These results revealed a divergence of IKK-
NF-kB signaling in the gut. NEMO-mediated NF-kB activation
inhibits the death of IECs and loss of Paneth cells in the small in-
testine, while NF-kB-independent NEMO functions prevent IEC
death and inflammation in the colon.(C andG) Graphs depicting the percentage of crypts with cl. casp. 3 stained cells o
16 mice per genotype).
(D) Graphs depicting mRNA levels of the indicated genes in the colon of mice wi
(H) Graph depicting Paneth cell scores of ileal sections from mice with the indica
Scale bars represent 100 mm. See also Figure S4.
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in regulating inflammation has been the subject of debate.
Apoptosis is believed to be less inflammatory than necroptosis
due to the limited release of DAMPs by apoptotic cells (Paspar-
akis and Vandenabeele, 2015), although the consequences of
these distinct types of regulated cell death in the intestinal
epithelium remain poorly understood. Most dying IECs in the
NEMOIEC-KO mice stained for cleaved caspase-3, suggesting
that they died by apoptosis. Due to the absence of a reliable
marker for the identification of necroptotic cells inmouse tissues,
we were not able to assess and quantify the occurrence of nec-
roptosis in these mice. Our efforts to genetically dissect the
contribution of apoptosis and necroptosis of IECs in NEMOIEC-KO
mice also did not lead to unambiguous results. We attempted to
specifically address the contribution of IEC apoptosis by gener-
ating mice lacking both NEMO and FADD in the intestinal epithe-
lium and found that these mice developed intestinal inflamma-
tion. IEC death, Paneth cell loss, and colitis development in
NEMOIEC-KO mice were fully prevented by FADD epithelial
knockout combined with systemic RIPK3 deficiency, showing
that inhibition of both apoptotic and necroptotic death of IECs
protects these mice from intestinal pathology. However, since
FADD epithelial deficiency caused IEC necroptosis and colitis
in mice (Welz et al., 2011), a likely interpretation of these findings
is that FADD knockout might prevent apoptosis of NEMO-defi-
cient IECs, but at the same time renders them susceptible to
RIPK3-dependent necroptosis. RIPK3 deficiency alone did not
prevent Paneth cell loss but partially ameliorated colitis severity
in NEMOIEC-KO mice. These results show that necroptosis is not
involved in IEC death in the small intestine but indicate that it
could be partly implicated in the death of colonocytes and colitis
development in these mice. However, RIPK3 has been sug-
gested to also mediate apoptosis as well as cell-death-indepen-
dent functions relevant for inflammation. A recent study reported
that RIPK3 deficiency exacerbated DSS-induced colitis, which
was attributed to a function of RIPK3 in promoting the expres-
sion of cytokines required for efficient injury repair in dendritic
cells (Moriwaki et al., 2014). This proposed anti-inflammatory
function of RIPK3 opposes its predominantly pathogenic role
in the NEMOIEC-KO mice and is therefore unlikely to contribute
to the amelioration of colitis in NEMOIEC-KO Ripk3/ mice.
Furthermore, RIPK3 has been suggested to regulate inflamma-
some activation and IL-1b release in a necroptosis-independent
manner (Kang et al., 2013; Lawlor et al., 2015; Wang et al., 2014).
Therefore, because of the complex and as-yet incompletely un-
derstood functions of RIPK3 in cell death and inflammation, at
this stage it is unclear whether RIPK3 deficiency ameliorates
colitis in NEMOIEC-KOmice by inhibiting necroptosis or apoptosis
or other proinflammatory RIPK3 functions. Further experiments
will be required to dissect the potential role of necroptosis in
the development of colitis in NEMOIEC-KO mice.
Our results provide in vivo experimental evidence that RIPK1
kinase activity-dependent death of NEMO-deficient epithelialn colon and ileal sections from littermates with the indicated genotypes (n = 11–
th the indicated genotypes (n = 8–12 mice per genotype).
ted genotypes (n = 12–17 mice per genotype).
(legend on next page)
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cells triggers Paneth cell loss in the small intestine and severe
chronic inflammation in the colon. Different mechanisms trigger
RIPK1-dependent epithelial cell death in the small and large
intestine. TNFR1-mediated death of IECs causes microbiota-
dependent inflammation in the colon. In contrast, IEC death
and loss of Paneth cells occurs in the combined absence of
TNFR1, Fas and TRAILR2, and does not require the presence
of the microbiota, although germ-free conditions ameliorated
the pathology indicating that intestinal bacteria contribute to
the severity of the ileal phenotype. The upstream stimuli inducing
IEC death in ileal crypts in NEMOIEC-KO mice remain unclear.
TRIF-dependent TLR signaling, but also type I and type II inter-
feron receptors have been shown to induce RIPK1-dependent
cell death, suggesting that these receptors might contribute to
the death of NEMO-deficient enterocytes.
The molecular mechanisms by which NEMO and NF-kB
signaling prevent RIPK1-mediated IEC death remain unclear.
Earlier in vitro studies in cell lines suggested that NEMO interacts
with RIPK1 via its ubiquitin-binding domain and prevents the
engagement of FADD/caspase-8 to trigger apoptosis (Le-
garda-Addison et al., 2009) or, when caspase 8 is inhibited,
necroptosis (O’Donnell et al., 2012). However, in these in vitro
studies RIPK1 kinase activity was suggested to be required for
necroptosis but not for apoptosis of NEMO deficient cells
(O’Donnell et al., 2012), while our results suggest that RIPK1
causes intestinal pathology primarily by inducing IEC apoptosis.
A recent study suggested that IKK1 and IKK2 prevent TNF-
induced cell death by directly phosphorylating RIPK1 and inhib-
iting RIPK1-induced death signaling independently of NF-kB,
and proposed that loss of IKK1/2 or NEMO causes RIPK1-
dependent death while NF-kB inhibition causes RIPK1-indepen-
dent cell death downstream of TNFR1 signaling (Dondelinger
et al., 2015). However, our results showing that RIPK1 kinase ac-
tivity mediates death of NEMO- or p65-deficient IECs but also
embryonic lethality of NEMO- or p65-deficient mice provide
in vivo experimental evidence that NF-kB signaling also controls
RIPK1-mediated cell death. These results suggest that IKK/NF-
kB signaling acts at multiple levels both by directly interacting
with upstream components of the cell death machinery such
as RIPK1, but also by inducing the expression of pro-survival
genes. NEMO could directly bind RIPK1 via its ubiquitin binding
domain and this interaction might be important to prevent the
formation of the RIPK1-containing signaling complex. Indeed,
our immunoprecipitation experiments suggested that NEMO
deficiency triggers the formation of a RIPK1/FADD/caspase-8
apoptosis-inducing signaling complex. Further studies will be
required to dissect the IKK- and NF-kB-dependent mechanisms
regulating RIPK1-induced cell death.Figure 6. Lack of RIPK1 Kinase Activity Prevents Colitis Development
(A and E) Representative images of colon and ileal sections from mice with the in
(B and F) Graphs depicting histopathological scores of colon and ileal sections f
(C and I) Graphs depicting the percentage of crypts with cl. casp. 3 stained cells on
mice per genotype).
(D, H) Graphs depicting mRNA levels of the indicated genes in the colon and ileu
(G) Graph depicting Paneth cell scores of ileal sections from mice with the indica
(J) Immunoblot analysis of the indicated proteins co-immunoprecipitated with FA
three independent experiments shown).
Scale bars represent 100 mm.
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functionally implicated in the development of intestinal inflam-
mation in these patients, presumably by inducing dysbiosis
(Blumberg and Powrie, 2012; Kaser et al., 2010). Our results
showing that RelAIEC-KO mice exhibit extensive loss of Paneth
cells but do not develop spontaneous intestinal inflammation
suggest that death of Paneth cells is not sufficient to disrupt ho-
meostasis and cause ileitis or colitis even in the presence of an
underlying NF-kB defect in the intestinal epithelium. However,
although Paneth cell loss is not sufficient by itself to cause the
disease, it might contribute to the development of colitis in
NEMOIEC-KO mice.
Human patients with hypomorphic NEMO mutations develop
ectodermal dysplasia accompanied with severe immunodefi-
ciency (EDA-ID) and about 25% of these patients suffer from in-
flammatory colitis (Hanson et al., 2008; Kawai et al., 2012).
Hematopoietic stem cell transplantation (HSCT) has been used
for the treatment of immunodeficiency in EDA-ID patients (Fish
et al., 2009; Pai et al., 2008). Although HSCT could successfully
restore immune function, it did not improve but rather worsened
colitis (Fish et al., 2009; Pai et al., 2008), suggesting that stromal
NEMO deficiency causes colitis in human EDA-ID patients
similarly to our mouse model with epithelial specific NEMO
knockout. TNF neutralizing antibodies were effective in treating
colitis in EDA-ID (Mizukami et al., 2012), showing that similarly
to NEMOIEC-KO mice, TNF causes colitis in the human patients.
However, considering the impaired immune function of NEMO
EDA-ID patients, additional treatment with anti-TNF increases
the risk of serious bacterial infections. Our results that inhibition
of RIPK1 kinase activity prevented the development of intestinal
pathology in NEMOIEC-KO mice suggest that RIPK1 kinase inhib-
itors could be highly effective for the treatment of gastrointestinal
complications in human patients with EDA-ID caused by NEMO
mutations, in particular after successful restoration of immune
function by HSCT. Because knockin mice expressing kinase
inactive RIPK1 do not show any abnormalities, RIPK1 kinase in-
hibitors are expected to be well tolerated and should therefore
be superior to anti-TNF treatment for these patients. Intestinal
epithelial cell death is commonly observed in patients with
inflammatory bowel diseases, including CD and UC (Seidelin
and Nielsen, 2009; Souza et al., 2005). Although mutations in
NEMO have not been associated with IBD, considering that
anti-TNF therapy is highly effective in the treatment of CD and
UC and reduces epithelial cell death (Zeissig et al., 2004), it is
tempting to speculate that RIPK1 kinase activitymight contribute
to the pathogenic role of TNF in human IBD patients by triggering
intestinal epithelial cell death. In the absence of evidence that
RIPK1-induced epithelial cell death occurs and is functionallyand Paneth Cell Loss in NEMOIEC-KO Mice
dicated genotypes.
rom mice with the indicated genotypes (n = 6–13 mice per genotype).
colon and ileal sections from littermates with the indicated genotypes (n = 4–12
m of mice with the indicated genotypes (n = 6 or 7 mice per genotype).
ted genotypes (n = 6–10 mice per genotype).
DD from total colon lysates from mice with the indicated genotypes (one out of
(legend on next page)
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relevant for the pathogenesis of IBD, this remains an interesting
hypothesis that awaits experimental validation.
EXPERIMENTAL PROCEDURES
Mice
Mice were maintained at the SPF animal facilities of the Institute for Genetics
and the CECADResearch Center, University of Cologne, under a 12 hr light cy-
cle and were given a regular chow diet (Harlan, diet no. 2918) and water ad li-
bitum. Germ-free mice were produced at the gnotobiotic facility of the
University of Ulm. All animal procedures were conducted in accordance with
European, national, and institutional guidelines, and protocols were approved
by local government authorities (Landesamt fu¨r Natur, Umwelt und Verbrau-
cherschutz Nordrhein-Westfalen). Animals requiring medical attention were
provided with appropriate care and excluded from the experiments described.
No other exclusion criteria existed. Detailed description can be found in the
Supplemental Information.
IEC Isolation and Immunoblotting
IECs were isolated by subsequent incubation of intestinal tissue in 1 mM di-
thiothreitol (DTT) and 1.5 mM EDTA solutions as described previously (Dan-
nappel et al., 2014). Cell lysis buffer was supplemented with protease and
phosphatase inhibitor tablets (Roche). Cell lysates were separated on SDS-
PAGE and transferred to PVDF membranes (IPVH00010, Millipore). Primary
antibodies used for immunoblot analysis: RelA C-20 (sc-372), RelB C-19 (sc-
226), and c-Rel (sc-71), b-actin 1-19 (sc-161) and HDAC1 H-51 (sc-7872)
from Santa Cruz, TNFR1 (D317K); Caspase 3 (9662), cleaved Caspase 3
(9661) from Cell Signaling; RIPK1 (610459) from BD; RIPK3 (ADI-905-242-
100) from Enzo Life Sciences; FADD (1F7) 05-486 from Upstate; Cre 69050-
3 from Novagen; Caspase-8 (ALX-804-447) from Alexis; and NEMO (home-
made rabbit polyclonal serum) and a-tubulin (T6074) from Sigma. Secondary
HRP-coupled antibodies (GE Healthcare, Jackson Immuno Research) and
chemiluminescent detection substrate (GE Healthcare and Thermo Scientific)
were used. For immunoprecipitation, colon tissue was lysed in IP buffer and
FADD was precipitated with goat anti-FADD (M19) (sc-6036) antibody from
Santa Cruz linked to protein G Dynabeads (Life Technologies). After extensive
washes, beads were boiled in SDS-containing sample buffer.
Histology and Immunohistochemistry
Intestinal tissues were fixed in 4% paraformaldehyde, embedded in paraffin,
and cut in 3 mm sections. For histopathological analysis, hematoxylin and
eosin staining was performed according to standard protocol. For immunohis-
tochemical (IHC) staining paraffin sections were rehydrated and heat-induced
antigen retrieval was performed in citrate buffer at pH 6.0. Primary antibodies
for IHCwere anti-cleaved caspase 3 Asp175 (9661, Cell Signaling), anti-human
lysozyme (F0372, Dako) and RelA C-20 (sc-372), Santa Cruz. Biotinylated sec-
ondary antibodies were purchased from Perkin Elmer and Dako. Stainings
were visualized with ABC Kit Vectastain Elite (Vector Laboratories) or Strepta-
vidin-HRP (Millipore) and DAB substrate (DAKO and Vector Laboratories).
Incubation times with DAB substrate were equal for all samples. Histopatho-
logical evaluation of tissue sections was performed as described in the Sup-
plemental Information.
Intestinal Organoid Culture
Small intestinal organoids were isolated and cultured as described previously
(Dannappel et al., 2014). After passaging, cultures were grown for 2 to 3 daysFigure 7. Epithelial NF-kB Deficiency Does Not Trigger Colitis but Cau
(A, F, and J) Representative images of colon and ileal sections from mice with th
(B, G, and K) Graphs depicting histopathological scores of colon and ileal sectio
(C, H, and L) Graphs depicting the percentage of crypts with cl. casp. 3 stained
(n = 4–12 mice per genotype).
(D and M) Graphs depicting Paneth cell scores of ileal sections from mice with th
(E, I, and N) Graphs depicting mRNA levels of the indicated genes in the colon a
Scale bars represent 100 mm. See also Figures S5 and S6.
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cultures were collected for RNA extraction.
Statistics
Statistical analysis was performed with Prism6, GraphPad applying Student’s
t tests with Welch’s correction in case of unequal variance. *p% 0.05; **p%
0.01; ***p% 0.005;****p% 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.immuni.2016.02.020.
AUTHOR CONTRIBUTIONS
K.V. and A.W. performed the experiments and analyzed data. A.P. generated
the Ripk1D138N/D138N mice and performed and analyzed the Nemo/
Ripk1D138N/D138N crosses. V.K. performed and analyzed immunoprecipitation
experiments and the RelA/ Ripk1D138N/D138N crosses. M.D. evaluated
cleaved caspase-3 stainings. R.S. performed FACS analysis of IECs. P.W.
generated and initially characterized NEMOIEC-KO FADDIEC-KO Ripk3/
mice. T.C. performed qRT-PCR analysis. M.K. designed and generated the
targeting constructs for Ripk1D138N/D138N mice. H.W. contributed TrailrFL
mice, F.W. contributed RelBFL mice, and U.K. contributed c-RelFL mice.
M.P. coordinated the project and together with K.V. wrote the paper.
ACKNOWLEDGMENTS
Weare grateful to V. Dixit andGenentech forRipk3/, G. Kollias for Tnfr1FL, D.
Gumucio for Villin-Cre, and S. Robine for Villin-CreERT2 mice, and to P. Kirsch
and the gnotobiotic facility at the University of Ulm for the generation of germ-
free NEMOIEC-KOmice. We thank J. Buchholz, C. Uthoff-Hachenberg, E. Mahl-
berg, B. Ku¨hnel, B. Hu¨lser, E. Stade, and D. Beier for technical assistance.
Research reported in this publication was supported by funding from the
ERC (grant agreement no. 323040), the DFG (SFB670, SPP1656), and the
European Commission (grants 223404 and 223151) to M.P., and by the NIAID
division of the NIH under award RO1AI075118 to M.K.
Received: April 22, 2015
Revised: October 25, 2015
Accepted: December 14, 2015
Published: March 15, 2016
REFERENCES
Alcamo, E., Mizgerd, J.P., Horwitz, B.H., Bronson, R., Beg, A.A., Scott, M.,
Doerschuk, C.M., Hynes, R.O., and Baltimore, D. (2001). Targeted mutation
of TNF receptor I rescues the RelA-deficient mouse and reveals a critical
role for NF-kappa B in leukocyte recruitment. J. Immunol. 167, 1592–1600.
Blumberg, R., and Powrie, F. (2012). Microbiota, disease, and back to health: a
metastable journey. Sci. Transl. Med. 4, 137rv7.
Dannappel, M., Vlantis, K., Kumari, S., Polykratis, A., Kim, C., Wachsmuth, L.,
Eftychi, C., Lin, J., Corona, T., Hermance, N., et al. (2014). RIPK1 maintains
epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513,
90–94.ses RIPK1 Kinase Dependent Paneth Cell Death
e indicated genotypes.
ns from mice with the indicated genotypes (n = 5–18 mice per genotype).
cells on colon and ileal sections from littermates with the indicated genotypes
e indicated genotypes (n = 4–12 mice per genotype).
nd ileum of mice with the indicated genotypes (n = 5–12 mice per genotype).
Dillon, C.P., Weinlich, R., Rodriguez, D.A., Cripps, J.G., Quarato, G., Gurung,
P., Verbist, K.C., Brewer, T.L., Llambi, F., Gong, Y.N., et al. (2014). RIPK1
blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157,
1189–1202.
Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough,
P.J., Giansanti, P., Heck, A.J., Dejardin, E., Vandenabeele, P., and Bertrand,
M.J. (2015). NF-kB-Independent Role of IKKa/IKKb in Preventing RIPK1
Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF
Signaling. Mol. Cell 60, 63–76.
Eckmann, L., Nebelsiek, T., Fingerle, A.A., Dann, S.M., Mages, J., Lang, R.,
Robine, S., Kagnoff, M.F., Schmid, R.M., Karin, M., et al. (2008). Opposing
functions of IKKbeta during acute and chronic intestinal inflammation. Proc.
Natl. Acad. Sci. USA 105, 15058–15063.
Fish, J.D., Duerst, R.E., Gelfand, E.W., Orange, J.S., and Bunin, N. (2009).
Challenges in the use of allogeneic hematopoietic SCT for ectodermal
dysplasia with immune deficiency. Bone Marrow Transplant. 43, 217–221.
Hanson, E.P., Monaco-Shawver, L., Solt, L.A., Madge, L.A., Banerjee, P.P.,
May, M.J., and Orange, J.S. (2008). Hypomorphic nuclear factor-kappaB
essential modulator mutation database and reconstitution system identifies
phenotypic and immunologic diversity. J Allergy Clin Immunol 122, 1169–
1177.e1116.
Hooper, L.V., Littman, D.R., and Macpherson, A.J. (2012). Interactions be-
tween the microbiota and the immune system. Science 336, 1268–1273.
Ireland, H., Houghton, C., Howard, L., and Winton, D.J. (2005). Cellular inher-
itance of a Cre-activated reporter gene to determine Paneth cell longevity in
the murine small intestine. Dev. Dyn. 233, 1332–1336.
Kang, T.B., Yang, S.H., Toth, B., Kovalenko, A., and Wallach, D. (2013).
Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflamma-
some. Immunity 38, 27–40.
Karin, M., and Greten, F.R. (2005). NF-kappaB: linking inflammation and
immunity to cancer development and progression. Nat. Rev. Immunol. 5,
749–759.
Kaser, A., Zeissig, S., and Blumberg, R.S. (2010). Inflammatory bowel disease.
Annu. Rev. Immunol. 28, 573–621.
Kawai, T., Nishikomori, R., and Heike, T. (2012). Diagnosis and treatment
in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol. Int. 61,
207–217.
Lawlor, K.E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B.A., D’Cruz, A.A.,
Hall, C., Kaur Spall, S., Anderton, H., Masters, S.L., et al. (2015). RIPK3 pro-
motes cell death and NLRP3 inflammasome activation in the absence of
MLKL. Nat. Commun. 6, 6282.
Legarda-Addison, D., Hase, H., O’Donnell, M.A., and Ting, A.T. (2009). NEMO/
IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint
during TNF signaling. Cell Death Differ. 16, 1279–1288.
Mizukami, T., Obara, M., Nishikomori, R., Kawai, T., Tahara, Y., Sameshima,
N., Marutsuka, K., Nakase, H., Kimura, N., Heike, T., and Nunoi, H. (2012).
Successful treatment with infliximab for inflammatory colitis in a patient with
X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J. Clin.
Immunol. 32, 39–49.
Moriwaki, K., Balaji, S., McQuade, T., Malhotra, N., Kang, J., and Chan, F.K.
(2014). The necroptosis adaptor RIPK3 promotes injury-induced cytokine
expression and tissue repair. Immunity 41, 567–578.
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth,
M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007). Epithelial NEMO links
innate immunity to chronic intestinal inflammation. Nature 446, 557–561.
O’Donnell, M.A., Hase, H., Legarda, D., and Ting, A.T. (2012). NEMO inhibits
programmed necrosis in an NFkB-independent manner by restraining RIP1.
PLoS ONE 7, e41238.Oeckinghaus, A., and Ghosh, S. (2009). The NF-kappaB family of transcription
factors and its regulation. Cold Spring Harb. Perspect. Biol. 1, a000034.
Ouellette, A.J. (2010). Paneth cells and innate mucosal immunity. Curr. Opin.
Gastroenterol. 26, 547–553.
Pai, S.Y., Levy, O., Jabara, H.H., Glickman, J.N., Stoler-Barak, L., Sachs, J.,
Nurko, S., Orange, J.S., andGeha, R.S. (2008). Allogeneic transplantation suc-
cessfully corrects immune defects, but not susceptibility to colitis, in a patient
with nuclear factor-kappaB essential modulator deficiency. J Allergy Clin
Immunol 122, 1113–1118.e1111.
Pasparakis, M. (2009). Regulation of tissue homeostasis by NF-kappaB signal-
ling: implications for inflammatory diseases. Nat. Rev. Immunol. 9, 778–788.
Pasparakis, M., and Vandenabeele, P. (2015). Necroptosis and its role in
inflammation. Nature 517, 311–320.
Permaul, P., Narla, A., Hornick, J.L., and Pai, S.Y. (2009). Allogeneic hemato-
poietic stem cell transplantation for X-linked ectodermal dysplasia and immu-
nodeficiency: case report and review of outcomes. Immunol. Res. 44, 89–98.
Peyrin-Biroulet, L. (2010). Anti-TNF therapy in inflammatory bowel diseases: a
huge review. Minerva Gastroenterol. Dietol. 56, 233–243.
Polykratis, A., Hermance, N., Zelic, M., Roderick, J., Kim, C., Van, T.M., Lee,
T.H., Chan, F.K., Pasparakis, M., and Kelliher, M.A. (2014). Cutting edge:
RIPK1 Kinase inactive mice are viable and protected from TNF-induced nec-
roptosis in vivo. J. Immunol. 193, 1539–1543.
Rickard, J.A., O’Donnell, J.A., Evans, J.M., Lalaoui, N., Poh, A.R., Rogers, T.,
Vince, J.E., Lawlor, K.E., Ninnis, R.L., Anderton, H., et al. (2014). RIPK1 regu-
lates RIPK3-MLKL-driven systemic inflammation and emergency hematopoi-
esis. Cell 157, 1175–1188.
Seidelin, J.B., and Nielsen, O.H. (2009). Epithelial apoptosis: cause or conse-
quence of ulcerative colitis? Scand. J. Gastroenterol. 44, 1429–1434.
Souza, H.S., Tortori, C.J., Castelo-Branco, M.T., Carvalho, A.T., Margallo,
V.S., Delgado, C.F., Dines, I., and Elia, C.C. (2005). Apoptosis in the intestinal
mucosa of patients with inflammatory bowel disease: evidence of altered
expression of FasL and perforin cytotoxic pathways. Int. J. Colorectal Dis.
20, 277–286.
Steinbrecher, K.A., Harmel-Laws, E., Sitcheran, R., and Baldwin, A.S. (2008).
Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic
homeostasis and susceptibility to inflammation. J. Immunol. 180, 2588–2599.
Takahashi, N., Vereecke, L., Bertrand,M.J., Duprez, L., Berger, S.B., Divert, T.,
Gonc¸alves, A., Sze, M., Gilbert, B., Kourula, S., et al. (2014). RIPK1 ensures
intestinal homeostasis by protecting the epithelium against apoptosis.
Nature 513, 95–99.
Van Hauwermeiren, F., Armaka, M., Karagianni, N., Kranidioti, K.,
Vandenbroucke, R.E., Loges, S., Van Roy, M., Staelens, J., Puime`ge, L.,
Palagani, A., et al. (2013). Safe TNF-based antitumor therapy following
p55TNFR reduction in intestinal epithelium. J. Clin. Invest. 123, 2590–2603.
Wang, X., Jiang, W., Yan, Y., Gong, T., Han, J., Tian, Z., and Zhou, R. (2014).
RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-
RIP3-DRP1 signaling pathway. Nat. Immunol. 15, 1126–1133.
Welz, P.S., Wullaert, A., Vlantis, K., Kondylis, V., Ferna´ndez-Majada, V.,
Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., and Pasparakis, M.
(2011). FADD prevents RIP3-mediated epithelial cell necrosis and chronic
intestinal inflammation. Nature 477, 330–334.
Zaph, C., Troy, A.E., Taylor, B.C., Berman-Booty, L.D., Guild, K.J., Du, Y.,
Yost, E.A., Gruber, A.D., May, M.J., Greten, F.R., et al. (2007). Epithelial-cell-
intrinsic IKK-beta expression regulates intestinal immune homeostasis.
Nature 446, 552–556.
Zeissig, S., Bojarski, C., Buergel, N., Mankertz, J., Zeitz, M., Fromm, M., and
Schulzke, J.D. (2004). Downregulation of epithelial apoptosis and barrier repair
in active Crohn’s disease by tumour necrosis factor alpha antibody treatment.
Gut 53, 1295–1302.Immunity 44, 553–567, March 15, 2016 ª2016 The Authors 567
